BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
376.65
-0.21 (-0.06%)
Aug 20, 2026, 7:58 AM EDT - Market open
BeOne Medicines AG Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 42,826 | 31,681 | 32,964 | 33,619 | 37,508 | 26,594 | 29,271 | 19,667 | 23,875 | 15,088 | 16,331 | 18,862 | 19,042 | 18,810 | 22,515 | 22,843 | 13,973 | 16,734 | 19,409 | 27,843 | 33,878 | |
Market Cap Growth (YoY) | 21.93% | 19.13% | 12.61% | 70.94% | 57.10% | 76.26% | 79.23% | 4.27% | 25.38% | -19.79% | -27.46% | -17.43% | 36.28% | 12.40% | 16.00% | -17.96% | -58.76% | -47.36% | -39.19% | 18.51% | 30.51% |
Enterprise Value | 39,777 | 28,943 | 30,416 | 31,487 | 35,778 | 25,075 | 27,724 | 18,005 | 22,372 | 13,433 | 14,087 | 16,441 | 16,204 | 15,886 | 18,576 | 18,473 | 8,902 | 11,161 | 13,486 | 24,626 | 30,177 |
Last Close Price | 376.86 | 284.97 | 296.97 | 303.81 | 340.70 | 242.07 | 272.17 | 184.71 | 224.51 | 142.67 | 156.39 | 180.36 | 179.87 | 178.30 | 215.53 | 219.94 | 134.82 | 161.85 | 188.60 | 270.93 | 363.00 |
Price Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | 67.42 | 48.32 | 64.25 | 117.17 | 547.17 | -149.71 | -74.60 | - | - | - | - | - | -19.49 | - | - | - | - | - | - | - | - |
Forward PE | 47.60 | 40.13 | 54.01 | 66.95 | 80.95 | 106.02 | 188.25 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 |
PS Ratio | 6.99 | 5.17 | 5.74 | 6.29 | 7.54 | 5.83 | 7.01 | 5.16 | 7.18 | 4.95 | 6.02 | 7.83 | 8.88 | 10.39 | 14.46 | 16.13 | 11.18 | 15.66 | 22.13 | 23.67 | 31.89 |
PB Ratio | 8.23 | 6.12 | 6.93 | 7.71 | 9.08 | 7.05 | 8.36 | 5.90 | 6.93 | 4.48 | 4.86 | 5.33 | 5.06 | 4.95 | 5.42 | 5.21 | 3.00 | 3.16 | 3.30 | 4.54 | 10.09 |
P/TBV Ratio | 8.38 | 6.20 | 7.02 | 7.82 | 9.23 | 7.18 | 8.49 | 5.99 | 7.18 | 4.56 | 4.94 | 5.42 | 5.13 | 5.01 | 5.47 | 5.26 | 3.03 | 3.18 | 3.32 | 4.58 | 10.13 |
P/FCF Ratio | 32.21 | 23.82 | 29.57 | 35.70 | 68.87 | 108.62 | - | - | -21.00 | - | - | - | - | - | - | - | - | - | - | - | - |
P/OCF Ratio | 28.87 | 21.35 | 25.66 | 29.82 | 47.76 | 46.56 | 138.06 | -139.85 | -39.04 | - | - | - | -17.99 | - | - | - | - | - | - | - | - |
EV Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 6.49 | 4.72 | 5.30 | 5.89 | 7.20 | 5.50 | 6.64 | 4.72 | 6.73 | 4.41 | 5.20 | 6.83 | 7.56 | 8.77 | 11.93 | 13.05 | 7.12 | 10.45 | 15.38 | 20.94 | 28.40 |
EV/EBITDA Ratio | 37.14 | 27.01 | 36.85 | 54.40 | 108.75 | 313.58 | -228.75 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EV/EBIT Ratio | 43.12 | 31.35 | 44.34 | 70.42 | 195.85 | -249.00 | -93.74 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EV/FCF Ratio | 29.92 | 21.76 | 27.29 | 33.44 | 65.70 | 102.41 | - | - | -19.68 | - | - | - | - | - | - | - | - | - | - | - | - |
Financial Efficiency
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.40 | 0.40 | 0.43 | 0.46 | 0.46 | 0.27 | 0.28 | 0.32 | 0.31 | 0.32 | 0.32 | 0.26 | 0.15 | 0.18 | 0.13 | 0.14 | 0.15 | 0.12 | 0.11 | 0.11 | 0.21 |
Debt / EBITDA Ratio | 1.86 | 1.38 | 1.73 | 2.20 | 2.30 | 2.03 | 4.86 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Debt / FCF Ratio | 1.54 | 1.54 | 1.84 | 2.12 | 3.50 | 4.19 | - | - | -0.93 | - | - | - | - | - | - | - | - | - | - | - | - |
Net Debt / Equity Ratio | -0.59 | -0.59 | -0.57 | -0.58 | -0.52 | -0.46 | -0.43 | -0.46 | -0.48 | -0.45 | -0.51 | -0.63 | -0.69 | -0.75 | -0.80 | -0.90 | -0.94 | -0.96 | -0.95 | -0.97 | -0.96 |
Net Debt / EBITDA Ratio | -2.84 | -2.84 | -3.32 | -4.40 | -6.48 | -21.64 | 12.54 | 3.86 | 2.28 | 1.95 | 1.75 | 2.04 | 2.17 | 1.86 | 2.01 | 2.28 | 2.38 | 2.72 | 2.93 | 4.25 | 2.45 |
Net Debt / FCF Ratio | -2.29 | -2.29 | -2.46 | -2.70 | -3.91 | -7.07 | 8.42 | 2.44 | 1.46 | 1.20 | 1.18 | 1.33 | 1.62 | 1.28 | 1.49 | 2.16 | 2.18 | 2.67 | 2.89 | 3.80 | 2.46 |
Asset Turnover | 0.77 | 0.72 | 0.76 | 0.81 | 0.87 | 0.76 | 0.77 | 0.70 | 0.65 | 0.52 | 0.45 | 0.51 | 0.41 | 0.29 | 0.23 | 0.22 | 0.18 | 0.15 | 0.12 | 0.15 | |
Inventory Turnover | 1.10 | 0.99 | 1.04 | 1.00 | 1.52 | 1.32 | 1.33 | 1.39 | 1.56 | 1.24 | 1.16 | 1.21 | 1.04 | 1.24 | 1.13 | - | 7.27 | 7.08 | 7.46 | 9.74 | 11.90 |
Quick Ratio | 2.91 | 2.91 | 3.17 | 2.97 | 2.09 | 1.65 | 1.65 | 1.51 | 1.65 | 1.64 | 1.73 | 1.97 | 2.75 | 2.74 | 3.35 | 3.22 | 3.74 | 4.22 | 4.70 | 4.45 | 3.13 |
Current Ratio | 3.41 | 3.41 | 3.64 | 3.41 | 2.39 | 1.95 | 1.96 | 1.80 | 1.94 | 1.98 | 2.08 | 2.32 | 3.16 | 3.13 | 3.75 | 3.55 | 4.07 | 4.54 | 5.05 | 4.76 | 3.40 |
Return on Equity (ROE) | 19.09% | 19.94% | 6.27% | 12.64% | 10.38% | 0.15% | -17.93% | -14.25% | -14.32% | -29.13% | -36.15% | 20.95% | -38.32% | -32.64% | -39.42% | -44.79% | -40.45% | -28.97% | -49.80% | -50.33% | |
Return on Assets (ROA) | 9.17% | 7.46% | 5.85% | 5.85% | 3.62% | 0.47% | -3.38% | -5.21% | -4.71% | -11.39% | -16.60% | -5.06% | -13.64% | -15.05% | -17.91% | -15.54% | -14.27% | -13.39% | -20.74% | -21.38% | |
Return on Invested Capital (ROIC) | 11.89% | 11.43% | 4.33% | 6.85% | 4.14% | 0.04% | -4.45% | -6.59% | -6.13% | -17.87% | -30.96% | -9.93% | -35.51% | -58.00% | -128.45% | -169.51% | -161.56% | -170.82% | -331.13% | -2057.70% | |
Return on Capital Employed (ROCE) | 13.10% | 13.10% | 10.20% | 7.00% | 3.50% | -2.50% | -7.70% | -15.30% | -22.90% | -22.90% | -28.40% | -29.70% | -30.00% | -37.00% | -36.50% | -36.50% | -35.60% | -32.10% | -29.40% | -20.80% | -34.00% |
Yields
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Earnings Yield | 1.53% | 2.07% | 1.56% | 0.85% | 0.18% | -0.67% | -1.34% | -3.28% | -3.47% | -3.37% | -4.71% | -4.59% | -5.13% | -9.21% | -8.51% | -8.77% | -15.38% | -12.13% | -10.10% | -5.24% | -3.96% |
FCF Yield | 3.10% | 4.20% | 3.38% | 2.80% | 1.45% | 0.92% | -0.62% | -3.22% | -4.76% | -8.29% | -8.95% | -8.94% | -8.43% | -11.77% | -9.90% | -7.98% | -14.35% | -11.34% | -9.92% | -5.61% | -3.85% |
Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | 7.79% | - | - | - | - | - | - | - | - |
Buyback Yield / Dilution | -8.00% | -2.88% | -4.14% | -8.58% | -8.13% | -7.51% | -6.62% | -2.10% | -0.66% | -0.06% | -0.10% | -0.30% | -1.67% | -1.78% | -1.66% | -9.19% | -11.55% | -11.91% | -5.93% | -4.60% | -4.96% |